Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
Cellular and Molecular Life Sciences : CMLS|October 11, 2023
Infiltrating macrophages amplify doxorubicin-induced cardiac damage: role of catecholaminesJessica Gambardella, Gaetano Santulli, Antonella Fiordelisi, et al.
International Journal of Cardiology|September 27, 2020
The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern ItalyAntonio Desai, Giuseppe Voza, Silvia Paiardi, et al.
Atherosclerosis|December 25, 2016
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaqueAngela Serena Maione, Ersilia Cipolletta, Daniela Sorriento, et al.
Frontiers in Immunology|June 24, 2021
PD-L1 Dysregulation in COVID-19 PatientsFrancesco Sabbatino, Valeria Conti, Gianluigi Franci, et al.
Cardiovascular Diabetology|January 18, 2026
Lysolecithin reprogramming via LPCAT1 modulation restores endothelial function and prevents diabetes-associated dysmetabolismEduardo Maria Sommella, Concetta Iside, Paola Di Pietro, et al.
Journal of Clinical Medicine|February 27, 2026
Analysis of a Real-World Population Participating in a Cardiac Rehabilitation Program: Cognitive Impairment, Functional Capacity, and Therapy TitrationNicola Virtuoso, Francesca Palmieri, Francesco Loria, et al.
European Journal of Heart Failure|March 8, 2019
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicityMichele Russo, Fiorentina Guida, Lorella Paparo, et al.
Cardiovascular Research|June 24, 2015
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligationGiovanni Esposito, Gabriele Giacomo Schiattarella, Cinzia Perrino, et al.
ESC Heart Failure|March 17, 2026
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter StudyGiuseppe Dattilo, Roberto Licordari, Egidio Imbalzano, et al.
Hypertension (Dallas, Tex. : 1979)|May 16, 2024
Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of MetforminGaetano Santulli, Valeria Visco, Fahimeh Varzideh, et al.
Pageof 22